#ZMapp is an experimental mixture of three humanized monoclonal antibodies for immunological protection against the #Ebola virus, and manufactured in the Nicotiana plant (Here is #GMO in Action). On 4 August 2014 the drug was first tested on humans. It was administered to two Americans who had been infected with Ebola. Both people appeared to have had positive results
